Key result
Addition of quinidine to patients on maintenance digoxin therapy caused an unpredictably large increase in plasma digoxin levels and decreased renal clearance.
Why the study?
Does the addition of quinidine increase plasma digoxin levels in patients on maintenance digoxin therapy?
Observational (n=30)
Does the addition of quinidine increase plasma digoxin levels in patients on maintenance digoxin therapy?
Quinidine causes a clinically important and unpredictably large increase in plasma digoxin levels, necessitating close monitoring and appropriate dose reduction.
Answers are grounded in this paper and cite their sources.
May warrant digoxin monitoring with quinidine coadministration; leaves open need for randomized confirmation before routine dose changes.
1 Thirty patients on maintenance digoxin therapy and admitted for cardioversion of atrial fibrillation were closely monitored with regard to plasma levels of digoxin and quinidine. 2 Seventeen of these patients were kept on maintenance digoxin therapy. After an initial lag period of 6 to 18 h after the addition of quinidine their digoxin levels started to increase and had increased by between 20 and 330% after 3 days on quinidine. Side-effects attributed to the raised digoxin concentration occurred in 6 of these patients. 3 As studied in 5 of these 17 patients the renal clearance of digoxin decreased markedly when quinidine was added to the therapy. There was also a slight but significant reduction in creatinine clearance (n = 4). 4 In 13 patients digoxin was discontinued 36 h prior to the first quinidine dose. Also in these patients digoxin plasma levels increased significantly. 5 It is concluded that quinidine causes an unpredictably large increase in plasma digoxin and that this effect is probably at least initially to a large part due to a redistribution of digoxin in the body. The relative contributions of re-distribution and impaired renal clearance of digoxin to the increase in digoxin steady-state levels are presently unknown. 6 It is recommended that close monitoring of digoxin concentration and appropriate reduction of the maintenance dose is undertaken when quinidine is to be given to patients on digitalis therapy.
No takes yet. Share an insight, caveat, or question.
Dahlqvist et al. (1980) conducted an observational in Atrial fibrillation (n=30). Quinidine vs. Baseline (digoxin alone) was evaluated on Plasma levels of digoxin. Addition of quinidine to patients on maintenance digoxin therapy caused an unpredictably large increase in plasma digoxin levels and decreased renal clearance.
Synapse has enriched 10 related papers. Consider them for comparative context: